View correction statement:
This article refers to:
The Review by Kenneth C Anderson, Ola Landgren, Rebecca C Arend, Jeffrey Chou & Ira A Jacobs, ‘Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics’, which appeared in the October 2019 issue of Future Oncology 15(28), 3267–3281 (2019), was published without disclosing grant support from the National Institutes of Health (NIH; grant no. P30 CA008748). This has now been corrected.
The authors and editors of Future Oncology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.